消化肿瘤杂志-官方网站
过刊浏览

过刊浏览

onlinebrowsing

肿瘤出芽对早期结直肠癌内镜切除术后复发风险评估的临床意义

Clinical significance of tumor budding in risk assessment of recurrence after endoscopic resection of early colorectal cancer

发布日期:2023-07-28 20:41:28 阅读次数: 0 下载

 

作者:李正勇,郑希敏,王凯旋,刘祺

 

单位:湖南师范大学附属第一医院湖南省人民医院 普通外科, 湖南 长沙 410000

 

Authors:  Li Zhengyong, Zheng Ximin, Wang Kaixuan, Liu Qi

 

Unit:  Department of General Surgery, the First Affiliated Hospital of Hunan Normal University, Hunan Provincial People's Hospital, Changsha 410000, Hunan, China

 

摘要:

目的 探讨肿瘤出芽对早期结直肠癌内镜切除术后复发风险评估的临床意义。方法 回顾性收集自20111月到201612月湖南省人民医院经内镜下治疗的低复发风险的34T1N0M0期结直肠癌患者的临床病理资料。分析患者的临床病理特征及5年无病生存情况。结果 34例患者中,高级别肿瘤出芽9(26.5%)、中级别肿瘤出芽12(35.3%)、低级别肿瘤出芽13(38.2%)。其中24(70.6%)5年随访期间内出现肿瘤复发,10(29.4%)例未出现肿瘤复发,低级别肿瘤出芽复发5(38.5%),中级别肿瘤出芽复发10(83.3%),高级别肿瘤出芽复发9(100%);5年随访期内3(8.8%)患者出现肿瘤相关性死亡。高级别肿瘤出芽多为广基底、中分化、5年内多复发(χ2值分别为9.1818.82110.432,P<0.05),经单因素分析显示经内镜治疗后患者的5年无病生存期与肿瘤出芽、基底部类型、分化类型明显相关(P值分别为0.0020.0120.001),多因素Cox回归分析显示,肿瘤出芽级别显著影响无病生存期(P=0.039)结论 肿瘤出芽是提示结直肠癌经内镜切除治疗后早期复发及转移的重要因素,肿瘤出芽计数可作为结直肠癌经内镜切除术后病理诊断的常规项目,便于临床进行预后评估;对病理结果提示高级别肿瘤出芽的患者,建议进一步追加外科手术或其他相关治疗。

 

关键词:早期结直肠癌; 内镜治疗; 肿瘤出芽; 风险评估

 

Abstract

Objective The purpose of this study was to investigate the clinical significance of tumor budding in the risk assessment of recurrence after endoscopic resection for early colorectal cancer CRC. Method The data of 34 patients with stage T1N0M0 colorectal cancer who received endoscopic treatment in Hunan Provincial People's Hospital from January 2011 to December 2016 were retrospectively collected. The clinicopathological characteristics and 5 -year disease-free survival of the patients were analyzed. Results Among the 34 patients, 9 cases 26.5% had high-grade tumor buds, 12 cases 35.3%had medium-grade tumor buds, and 13 cases 38.2% had low-grade tumor buds. During the 5-year follow-up, 24 patients 70.6% had tumor recurrence, 10 patients 29.4% had no tumor recurrence, low-grade tumor buds had 5 patients 38.5% recurrence, medium-grade tumor buds had 10 patients 83.3% recurrence, and high-grade tumor buds had 9 patients 100% recurrence. Tumor-related deaths occurred in 3 patients8.8% during the 5-year follow-up period. In this study, we found that the tumors in the high-grade budding group were mostly broad -based, moderately differentiated, and more recurrent within 5 years χ2 =9.1818.82110.432, all P0.05, Univariate analysis showed that the 5-year disease-free survival time after endoscopic treatment was significantly correlated with tumor germination, basal type and differentiation type P=0.002, 0.012, 0.001. Multivariate Cox regression analysis showed that tumor germination level significantly affected the disease-free survival time P=0.039 . Conclusion Tumor budding is an important factor for early recurrence and metastasis of colorectal cancer after endoscopic resection. The count of tumor budding can be used as a routine item for pathological diagnosis of colorectal cancer after endoscopic resection, which is convenient for clinical prognostic evaluation. For patients with high-grade tumor sprouting, additional surgery or other related treatment are recommended.

 

Key Words:  Early stage colorectal cancer; Endoscopy; Tumor budding; Risk assessment

上一篇:暂无上一篇

下一篇:暂无下一篇

友情链接
中国科学文献服务系统 中国期刊全文数据库 美国生物医学信息检索系统
E-mail
digestiveoncology@163.com
联系电话
020-87616240
编辑部地址
地址:广州越秀区中山二路58号5号楼19楼胃肠外科中心

关注我们

粤ICP备10090623号 技术支持:中网科技